当前位置:首页>产品中心>单抗/多抗>Anti-Human CIP2A Polyclonal Antibody|抗人CIP2A多克隆抗体(靶标:人蛋白磷酸酶2A抑制剂/CIP2A)

Anti-Human CIP2A Polyclonal Antibody|抗人CIP2A多克隆抗体(靶标:人蛋白磷酸酶2A抑制剂/CIP2A)

  • 货号:RB9THV712014
  • 价格:面议
  • 点击:396
   一键复制产品信息 复制成功!

产品介绍

产品参数

形态Liquid
宿主种属Rabbit
克隆性Polyclonal
抗体亚型IgG
纯化方式Purified by antigen affinity column.
内毒素水平Please contact with the lab for this information.
应用ELISA, IHC, WB
种属反应性Human
靶标CIP2A, Cancerous inhibitor of PP2A, KIAA1524, Protein CIP2A, p90 autoantigen
免疫原E. coli - derived recombinant Human CIP2A (Asp2-Glu560).
储存缓冲液0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
产品使用说明ELISA:1:5000-1:20000;IHC:1:50-1:500;WB:1:500-1:2000
登录号Q8TCG1
背景信息

Protein CIP2A is a ~102 kDa protein. Acts as an inhibitor of protein phosphatase PP2A. Promotes anchorage-independent cell growth and tumor formation by preventing dephosphorylation of MYC, thereby stabilizing MYC in human malignancies. Together with TOPBP1, plays an essential role in the response to genome instability generated by the presence of acentric chromosome fragments derived from shattered chromosomes within micronuclei. Micronuclei, which are frequently found in cancer cells, consist of chromatin surrounded by their own nuclear membrane: following breakdown of the micronuclear envelope, a process associated with chromothripsis, the CIP2A-TOPBP1 complex tethers chromosome fragments during mitosis to ensure clustered segregation of the fragments to a single daughter cell nucleus, facilitating re-ligation with limited chromosome scattering and loss.

1. Junttila, MR. et al. (2007) Cell 130, 51-62. PMID: 17632056
2. Adam, S. et al. (2021) Nature cancer 2, 1357-1371. PMID: 35121901
3. De Marco Zompit, M. et al. (2022) Nature communications 13, 4143. PMID: 35842428
4. Lin, YF. et al. (2023) Nature 618, 1041-1048. PMID: 37165191
5. Trivedi, P. et al. (2023) Nature 618, 1049-1056. PMID: 37316668
备注For research use only
【仅供科学研究使用】

相关产品:
产品名称 点击数
Research Grade Lunaxafusp|研究级Lunaxafusp(靶标:Lunaxafusp(研究用)) 961
Anti-Mouse C5 Recombinant Antibody|抗小鼠C5重组抗体(靶标:小鼠补体C5) 925
Anti-Pembrolizumab Neutralizing Recombinant Antibody |抗帕博利珠单抗中和重组抗体(靶标:帕博利珠单抗中和抗体) 844
Anti-Pembrolizumab Neutralizing Recombinant Antibody |抗帕博利珠单抗中和重组抗体(靶标:帕博利珠单抗中和抗体) 711
Anti-Human CD39/ENTPD1 Recombinant Antibody|抗人CD39/ENTPD1重组抗体(靶标:人外核苷酸三磷酸二磷酸水解酶1/CD39) 681
Anti-Glycophorin A (type M) Recombinant Antibody|抗血型糖蛋白A(M型)重组抗体(靶标:人血型糖蛋白A(M型)) 1073
Anti-Glycophorin A (type N) Recombinant Antibody|抗血型糖蛋白A(N型)重组抗体(靶标:人血型糖蛋白A(N型)) 687
Anti-Glycophorin A (type N) Recombinant Antibody|抗血型糖蛋白A(N型)重组抗体(靶标:人血型糖蛋白A(N型)) 978
Anti-Glycophorin A (type M) Recombinant Antibody|抗血型糖蛋白A(M型)重组抗体(靶标:人血型糖蛋白A(M型)) 735
Anti-Human α4β7/ITGA4 & ITGB7 Recombinant Antibody |抗人α4β7/ITGA4和ITGB7重组抗体(靶标:人整合素α4β7复合物) 585
Anti-Human CD2BP2 Polyclonal Antibody|抗人CD2BP2多克隆抗体(靶标:人CD2结合蛋白2) 903
InVivoMAb anti-Mouse IL-6R alpha&IL6R Antibody|InVivoMAb抗小鼠IL-6Rα和IL6R抗体(靶标:小鼠白细胞介素6受体) 883
Anti-Human EGFR/ERBB1/HER1 Reference Antibody|抗人EGFR/ERBB1/HER1参照抗体(靶标:人表皮生长因子受体(研究用)) 765
Anti-Human CD279/PD-1 Recombinant Antibody|抗人CD279/PD-1重组抗体(靶标:人程序性细胞死亡蛋白1/PD-1) 983
Anti-Human CD279/PD-1 Recombinant Antibody, FITC|抗人CD279/PD-1重组抗体, FITC标记(靶标:人程序性细胞死亡蛋白1/PD-1(FITC标记)) 872
Anti-Human CD279/PD-1 Recombinant Antibody, PE|抗人CD279/PD-1重组抗体, PE标记(靶标:人程序性细胞死亡蛋白1/PD-1(PE标记)) 725
Anti-Human CD279/PD-1 Recombinant Antibody, APC|抗人CD279/PD-1重组抗体, APC标记(靶标:人程序性细胞死亡蛋白1/PD-1(APC标记)) 955
Anti-Human CD279/PD-1 Recombinant Antibody, PerCP|抗人CD279/PD-1重组抗体, PerCP标记(靶标:人程序性细胞死亡蛋白1/PD-1(PerCP标记)) 898
Anti-Omalizumab Neutralizing Recombinant Antibody |抗奥马珠单抗中和重组抗体(靶标:奥马珠单抗中和抗体) 742
Anti-Omalizumab Neutralizing Recombinant Antibody |抗奥马珠单抗中和重组抗体(靶标:奥马珠单抗中和抗体) 640
总计 33037 个记录,共 1652 页,当前第 1643 页 | 第一页 上一页 下一页 最末页
在线客服
  • 销售热线:
  • 15898894496(同微信)
  • 我要留言
  • 周一至周日 9:00-22:30